Form 8-K - Current report:
SEC Accession No. 0001641172-25-020896
Filing Date
2025-07-25
Accepted
2025-07-24 19:00:46
Documents
17
Period of Report
2025-07-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 49696
2 EX-4.1 ex4-1.htm EX-4.1 128142
3 EX-4.2 ex4-2.htm EX-4.2 132023
4 EX-10.1 ex10-1.htm EX-10.1 51990
5 EX-99.1 ex99-1.htm EX-99.1 14456
6 GRAPHIC ex99-1_001.jpg GRAPHIC 12140
  Complete submission text file 0001641172-25-020896.txt   634816

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE pali-20250723.xsd EX-101.SCH 3023
8 XBRL LABEL FILE pali-20250723_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE pali-20250723_pre.xml EX-101.PRE 22364
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3683
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 251148163
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)